cbdMD (YCBD) EBIT Margin Growth (3y) (2019 - 2026)
cbdMD (YCBD) EBIT Margin Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 1,129.00 |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 2.00 |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 59.00 |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | -1,031.00 |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -925.00 |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | -46.00 |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 6,666.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | cbdMD | 5.41 Mn | 3.29 Mn | 3.04 Mn | 786.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 786.00 |
| Dec 31, 2025 | 5,913.00 |
| Sep 30, 2025 | 14,190.00 |
| Jun 30, 2025 | 36,587.00 |
| Mar 31, 2025 | 4,181.00 |
| Dec 31, 2024 | 25,342.00 |
| Sep 30, 2024 | 6,116.00 |
| Jun 30, 2024 | 5,142.00 |
| Mar 31, 2024 | -198.00 |
| Dec 31, 2023 | -643.00 |
| Sep 30, 2023 | -27,776.00 |
| Jun 30, 2023 | -1,743.00 |
| Mar 31, 2023 | 3,714.00 |
| Dec 31, 2022 | -613.00 |
| Sep 30, 2022 | -10,354.00 |
| Jun 30, 2022 | -31,908.00 |
| Mar 31, 2022 | -2,588.00 |
| Dec 31, 2021 | -9,545.00 |
| Sep 30, 2021 | -10,678.00 |
| Jun 30, 2021 | -9,269.00 |